TrialFrontiers in immunology2026

Exploratory genomic stratification of benefit from first-line immunotherapy-based combination in advanced biliary tract cancer: a biomarker analysis of a randomized phase 2 trial.

Yatong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.